Plus Therapeutics Inc (NASDAQ: PSTV) is -73.14% lower on its value in year-to-date trading and has touched a low of $0.24 and a high of $2.31 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PSTV stock was last observed hovering at around $0.31 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.31, the stock is -4.74% and -43.49% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.83 million and changing -1.62% at the moment leaves the stock -71.04% off its SMA200. PSTV registered -85.89% loss for a year compared to 6-month loss of -77.12%.
The stock witnessed a -39.02% gain in the last 1 month and extending the period to 3 months gives it a -47.29%, and is -11.31% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.90% over the week and 9.47% over the month.
Plus Therapeutics Inc (PSTV) has around 21 employees, a market worth around $10.10M and $5.21M in sales. Profit margin for the company is -520.90%. Distance from 52-week low is 28.71% and -86.63% from its 52-week high.
The EPS is expected to grow by 62.82% this year.
Plus Therapeutics Inc (PSTV) Top Institutional Holders
The shares outstanding are 32.72M, and float is at 29.81M with Short Float at 1.72%.
The top institutional shareholder in the company is AIGH CAPITAL MANAGEMENT LLC with over 0.57 million shares valued at $0.84 million. The investor’s holdings represent 8.7478% of the PSTV Shares outstanding. As of 2024-06-30, the second largest holder is GEODE CAPITAL MANAGEMENT, LLC with 46648.0 shares valued at $68572.0 to account for 0.7176 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 32541.0 shares representing 0.5006% and valued at over $47835.0, while CITADEL ADVISORS LLC holds 0.2812 of the shares totaling 18283.0 with a market value of $26876.0.
Plus Therapeutics Inc (PSTV) Insider Activity
#####
Plus Therapeutics Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Hawkins Richard J (Director) bought a total of 4,000 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $1.50 per share for $5996.0. Following the transaction, the insider now directly holds 15188.0 shares of the PSTV stock.
Still, SEC filings show that on Sep 12 ’24, Hawkins Richard J (Director) acquired 6,285 shares at an average price of $1.35 for $8512.0. The insider now directly holds 11,188 shares of Plus Therapeutics Inc (PSTV).
